Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Regulation

Acting FDA Commissioner Woodcock defends aducanumab approval

Woodcock said she wasn’t involved in the decision, and that the data were ‘solid’

June 15, 2021 10:08 PM UTC

Acting FDA Commissioner Janet Woodcock strongly defended the agency’s accelerated approval of Biogen’s Aduhelm aducanumab Tuesday, in an interview with BioCentury.

Woodcock, who said she wasn’t personally involved in making the decision, said it fits squarely within the agency’s standards for accelerated approval. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article